SkyAI Inc. (SKYA)
SKYA trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1737995/000149315226014261/0001493152-26-014261-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | SKYA on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001737995 |
| SEC industry code | Finance Services |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $204K |
| Net income | -$282.5M |
| Operating income | -$269.7M |
| Net margin | -138400.0% |
| Operating margin | -132145.5% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $10.4M |
| Total assets | $269.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 525.7× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-06 |
| Cash and burn | $7.5M cash; operating cash flow -$3.3M a quarter. | Report 2026-09-30 |
| Shares outstanding | 50,854,199 (2026-11-02); 28,226,153 a year earlier; 15,274,457 three years earlier. 3y figure adjusted for splits (1-for-6600 overall). | Cover page 2026-11-02 |
| Reverse splits, 3 years | 2; latest 1-for-300 on 2025-04-28 | Source 2025-04-28 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PKF O'Connor Davies, LLP, New York, New York, United States | PCAOB Form AP 2026-04-16 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $1.8M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $0 | $84.9M | -$3.5M | $7.5M | No debt tags | $193K | 10-Q 2026-11-06 |
| Q2 2026 2026-06-30 | $0 | -$23.3M | -$3.0M | $12.1M | No debt tags | $261K | 10-Q 2026-08-07 |
| Q1 2026 2026-03-31 | $193K | -$86.2M | -$2.7M | $12.3M | No debt tags | $397K | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $0 | -$182.7M | -$3.9M | $10.4M | $3.1M | $204K | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $68K | -$105.3M | -$4.8M | $10.5M | $7.6M | Needs four quarters | 10-Q 2026-11-06 |
| Q2 2025 2025-06-30 | $136K | $3.6M | -$859K | $8.3M | No debt tags | Needs four quarters | 10-Q 2026-08-07 |
| Q1 2025 2025-03-31 | Not filed | $1.9M | -$1.4M | $11.9M | No debt tags | Needs four quarters | 10-Q 2026-11-06 |
| Q4 2024 2024-12-31 | Not filed | -$4.5M | $771K | $755K | $3.8M | Needs four quarters | 10-K 2026-03-31 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-01-13 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-11-06 |
| Latest current report | 8-K | 2026-10-28 |
| Latest proxy | DEFA14A | 2026-09-14 |
Source: SEC EDGAR submissions feed, 360 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -21.4% |
| 1 month | -11.1% |
| 3 months | +132.0% |
| Year to date | +14.3% |
| 1 year | -27.7% |
| From 52-week high | -29.1% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| SKYAW | SkyAI Inc. Warrant | $0.0365 |
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| APYX | Apyx Medical Corporation | $2.65 | -5.69% | $111.6M |
| SKIN | SkinHealth Systems Inc. | $15.05 | -7.73% | $98.5M |
| STIM | Neuronetics Inc. | $1.25 | -10.07% | $120.6M |
| LUNG | Pulmonx Corporation | $2.80 | -2.10% | $121.9M |
| PYPD | PolyPid Ltd. | $6.15 | -1.76% | $124.9M |
| NYXH | Nyxoah SA | $0.8937 | -0.64% | $89.4M |
| LUCD | Lucid Diagnostics Inc. | $0.3978 | -11.42% | $82.3M |
| KRMD | KORU Medical Systems Inc. Common Stock (DE) | $3.69 | -0.27% | $160.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier